← Open Payments lookup

DEVON LAPPIN: Open Payments

NPI 1194235507 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,223 in 39 payments from 11 companies in 2025. Trend: 2023 $2,578 · 2024 $1,641 · 2025 $1,223

Food & beverage: $1,223
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$332
GENZYME CORPORATION7$261
Regeneron Healthcare Solutions, Inc.6$184
GlaxoSmithKline, LLC.10$152
Neurocrine BioSciences, Inc.1$103
Genentech USA, Inc.3$55
United Therapeutics Corporation2$37
Verona Pharma, Inc.2$35
Grifols USA, LLC1$29
Avadel CNS Pharmaceuticals, LLC1$18

Products named: DUPIXENT, BREZTRI, NUCALA, INGREZZA, AIRSUPRA, Xolair, TRELEGY ELLIPTA, Tyvaso.

Industry payments across NJ — which companies pay providers there.